[Discussion] we are measuring phase 2 at the wrong time and calling it noise
Long-ish post, sorry. tl;dr at the bottom. I have been tracking retatrutide against eGFR for 9 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
The glucagon component does different things than dual agonism. The early fullness are not just amplified versions.
phase 2 numbers are not maintenance numbers, cite the trial
That is net peptide content, not purity. Different number, different meaning.
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.